focus -WSS

focus

author：comprehensive 2025-08-28 08:47:01 - browse：5347

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： UnitedHealth’s board chair also owns a personal investment firm

focus

entertainment

WSS

FDA gives detailed accounting of AI

Listen: Who gets the credit for GLP

Listen: Who gets the credit for GLP

Will Ozempic

STAT Summit: Michael J. Fox on progress in Parkinson's research

Studies point to risks of excluding people with obesity from drug trials

knowledge

focus

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Hospital price transparency does save money, advocate argues

At least 13 dead in Texas as scorching temps continue

HHS leader on health, climate change and biopharma emissions

State Dept. review finds Biden bears some blame for Afghanistan failures

First Opinion Podcast: Long Covid needs a new approach

What does generative AI mean for health care? We asked experts

Biogen shutters digital health group, ends Apple study, in cost cutting move

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Summit: Michael J. Fox on progress in Parkinson's research

focus

First Opinion Podcast: Long Covid needs a new approach

Shingles, which affected Dianne Feinstein, is on the rise

Address the ethical violations that led to 'Three Identical Strangers'

The explosion of genetic testing requires a new approach

Paxlovid should be available without a positive Covid test

2023 STAT Wunderkinds: get to know the winners

Wikipedia

focus

entertainment

Wikipedia